Thursday, April 2, 2026
12:00 pm – 1:00 pm CT / 1:00 pm – 2:00 pm ET
Register
Cost: FREE for SIDP Members! $10 for non-member attendees
Description:
Pneumonia remains one of the most common indications for empiric antimicrobial therapy. Many patients with chronic respiratory tract disease are colonized with bacteria, yet positive culture results often trigger unnecessary antibiotic initiation. There are a variety of tools available to aid in diagnostic stewardship with a diverse degree of sophistication. Effective interventions range from education, to local policy change, to integrated EMR nudges, to statewide pay-for-performance initiatives.
This interprofessional education session will enhance participants’ understanding of diagnostic stewardship by exploring its clinical importance, outlining practical strategies for implementation, and examining real-world successes and challenges specific pneumonia. Participants will leave better equipped to collaborate across disciplines to optimize diagnostic practices and improve the appropriateness of testing and treatment decisions.
Agenda:
Following introductions, speakers will discuss diagnostic tests available for respiratory illness, outline success and challenges with diagnostic stewardship interventions, and describe the roles of physicians and pharmacists
Target Audience: An interprofessional audience, specifically pharmacists and physicians, involved in the diagnosis and management of infectious diseases. The content may also apply to advanced practice providers, nurses, microbiologists, infection preventionists, and other healthcare professionals.
Learning Objectives:
- Describe the risks of misdiagnosis and overdiagnosis of lower respiratory tratct infections
- Identify the strengths and weaknesses of diagnostic tests that are available to diagnose lower respiratory tract infections
- Compare and contrast the successes and challenges associated with implementation of diagnostic stewardship interventions for lower respiratory tract infections
- Describe the role of pharmacists and physicians on the healthcare team to promote diagnostic and antimicrobial stewardship
Faculty:
Christen Arena, PharmD, MLS (ASCP)
Assistant Professor
Pharmacy Practice and Administrative Sciences
University of Cincinnati
Cincinnati, OH
Daniel Taupin, MD, MHQS
Vice Chair, Quality, Department of Medicine
Clinical Assistant Professor of Medicine, Division of Infectious Diseases
Sidney Kimmel Medical College at Thomas Jefferson University
Philadelphia, PA
Accreditation:
Pharmacist
The Society of Infectious Diseases Pharmacists (SIDP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
UAN: 0672-0000-26-005-L01-P
CPE credit: 1.0 contact hour (0.1 CEU)
Type of activity: Knowledge
Release date: April 2, 2026
ACPE Activity Fee: SIDP Member: Free / Non-Member: $10
To receive CE credit, participants must view the CE content, complete a post-test, and complete an evaluation. Proof of completion will be submitted to NABP CPE Monitor.
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Participants are responsible for verifying credits were transferred successfully to your NABP eProfile account before the ACPE 60-day deadline. After the 60 day deadline, SIDP will no longer be able to report your credit(s) for this activity.
Funding: This activity is provided by SIDP. No external funding was received for this activity.
Disclosures: In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, SIDP asks all individuals involved in the development and presentation of CE activities to disclose all financial relationships with ineligible companies. All relevant financial relationships have been mitigated prior to the CE activity. The following financial relationships have been disclosed:
- Dr. Arena and Dr. Taupin have no relevant financial relationships with an ineligible company to disclose.
- Presentation title and objectives were written by the planning committee and enhanced by AI. All enhancements were reviewed by a human.
Disclaimer: Faculty members are asked to disclose when any unlabeled/investigational use of pharmaceuticals and devices is being discussed. This activity is intended for educational purposes and should not be used as a substitute for care or advice from a professional. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of SIDP.
The planners and faculty of this continuing education activity have made all reasonable efforts to ensure the accuracy of the information presented in accordance with the latest available scientific knowledge at the time of publication. Healthcare professionals should verify all information and data with recommendations of other authorities before treating patients or employing any therapies described in this continuing education activity.
.gif){kind=logo}